ATE534905T1 - Cop1-moleküle und verwendungen davon - Google Patents

Cop1-moleküle und verwendungen davon

Info

Publication number
ATE534905T1
ATE534905T1 AT04795352T AT04795352T ATE534905T1 AT E534905 T1 ATE534905 T1 AT E534905T1 AT 04795352 T AT04795352 T AT 04795352T AT 04795352 T AT04795352 T AT 04795352T AT E534905 T1 ATE534905 T1 AT E534905T1
Authority
AT
Austria
Prior art keywords
cop1
cop1 molecules
molecules
detecting
provides
Prior art date
Application number
AT04795352T
Other languages
English (en)
Inventor
David Dornan
Dorothy French
Vishva Dixit
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE534905T1 publication Critical patent/ATE534905T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Liquid Crystal Substances (AREA)
  • Artificial Filaments (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04795352T 2004-10-14 2004-10-14 Cop1-moleküle und verwendungen davon ATE534905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/034174 WO2006043938A1 (en) 2004-10-14 2004-10-14 Cop1 molecules and uses thereof

Publications (1)

Publication Number Publication Date
ATE534905T1 true ATE534905T1 (de) 2011-12-15

Family

ID=34959031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04795352T ATE534905T1 (de) 2004-10-14 2004-10-14 Cop1-moleküle und verwendungen davon

Country Status (11)

Country Link
US (2) US7785815B2 (de)
EP (2) EP2302388A1 (de)
JP (1) JP4678882B2 (de)
CN (1) CN101080638A (de)
AT (1) ATE534905T1 (de)
AU (2) AU2004324176B2 (de)
CA (1) CA2584197A1 (de)
IL (2) IL182500A0 (de)
MX (1) MX2007004342A (de)
NZ (1) NZ554438A (de)
WO (1) WO2006043938A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2302388A1 (de) 2004-10-14 2011-03-30 Genentech, Inc. COP1-Moleküle und deren Verwendungen
US10261321B2 (en) 2005-11-08 2019-04-16 Lumus Ltd. Polarizing optical system
JP2009521925A (ja) * 2005-12-31 2009-06-11 ジェネンテック・インコーポレーテッド リン酸化されたｃｏｐ１分子およびその使用
KR101711860B1 (ko) * 2008-01-25 2017-03-03 베르그 엘엘씨 발암성, 종양 진행 및 치료 효능을 평가하는 분석 시스템
WO2009117448A1 (en) * 2008-03-18 2009-09-24 Mendel Biotechnology, Inc. Enhancement of plant yield, vigor and stress tolerance
CA2775092A1 (en) * 2009-09-23 2011-03-31 Protiva Biotherapeutics, Inc. Compositions and methods for silencing genes expressed in cancer
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
IL235642B (en) 2014-11-11 2021-08-31 Lumus Ltd A compact head-up display system is protected by an element with a super-thin structure
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP7187022B2 (ja) 2016-10-09 2022-12-12 ルムス エルティーディー． 長方形導波路を使用する開口乗算器
KR102541662B1 (ko) 2016-11-08 2023-06-13 루머스 리미티드 광학 컷오프 에지를 구비한 도광 장치 및 그 제조 방법
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
WO2019016813A1 (en) 2017-07-19 2019-01-24 Lumus Ltd. LIQUID CRYSTAL LIGHTING ON SILICON VIA OPTICAL ELEMENT GUIDE OF LIGHT
CN113474715A (zh) 2019-02-28 2021-10-01 鲁姆斯有限公司 紧凑型准直图像投影仪
TWI916247B (zh) 2019-04-15 2026-02-21 以色列商魯姆斯有限公司 光導光學元件
JP7497079B2 (ja) 2019-12-08 2024-06-10 ルーマス リミテッド コンパクト画像プロジェクタを備える光学系
DE202021104723U1 (de) 2020-09-11 2021-10-18 Lumus Ltd. An ein optisches Lichtleiterelement gekoppelter Bildprojektor
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN119587474A (zh) * 2024-12-20 2025-03-11 中国人民解放军新疆军区总医院 一种肝靶向化疗药物纳米胶束制备方法、化疗药物及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5527676A (en) 1989-03-29 1996-06-18 The Johns Hopkins University Detection of loss of the wild-type P53 gene and kits therefor
AU1370592A (en) * 1991-02-01 1992-09-07 Oncogene Science, Inc. Immunoassay for detection of mutant p53 polypeptide in biological fluids
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US8053477B2 (en) * 2002-03-29 2011-11-08 University Of Maryland, Baltimore Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
DE60200248T2 (de) * 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
EP2302388A1 (de) 2004-10-14 2011-03-30 Genentech, Inc. COP1-Moleküle und deren Verwendungen

Also Published As

Publication number Publication date
IL182500A0 (en) 2007-09-20
US7785815B2 (en) 2010-08-31
EP2302388A1 (de) 2011-03-30
AU2010219438A1 (en) 2010-10-14
IL211255A0 (en) 2011-04-28
US20110045474A1 (en) 2011-02-24
AU2004324176A1 (en) 2006-04-27
US20080009458A1 (en) 2008-01-10
NZ554438A (en) 2009-11-27
CA2584197A1 (en) 2006-04-27
WO2006043938A1 (en) 2006-04-27
EP1802978A1 (de) 2007-07-04
CN101080638A (zh) 2007-11-28
JP4678882B2 (ja) 2011-04-27
JP2008517266A (ja) 2008-05-22
MX2007004342A (es) 2007-07-16
AU2004324176B2 (en) 2011-01-27
EP1802978B1 (de) 2011-11-23

Similar Documents

Publication Publication Date Title
IL182500A0 (en) Cop1 molecules and uses thereof
IL180997A0 (en) Diagnostic methods and kits utilizing platelet biomarkers for cancer
AU2006316189A8 (en) Novel quantitative and qualitative analysis apparatus for measuring the body fluid
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE433108T1 (de) Radiomarkierungssatz und bindungstest
GB0612649D0 (en) No title
DE602006002251D1 (de) Messvorrichtungsanzeigevorrichtung, anzeigeverfahren dafür und damit ausgestattetes hybridfahrzeug
AU305356S (en) Analyte test meter
ATE424560T1 (de) Marker für neuromyelitis optica
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
WO2008048970A3 (en) Synthetic antibodies
ATE513216T1 (de) Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome
WO2008048508A3 (en) Prognostic biomarkers in patients with ovarian cancer
WO2007092173A3 (en) Raman spectroscopic lateral flow test strip assays
EP2302382A3 (de) Docetaxel Konjugaten und Immunogenen zur Verwendung in einem Immunassay
DK1864129T3 (da) Doxurubicin-immunassay
ATE479898T1 (de) Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs
AU2006239318A8 (en) Cancer specific PCNA isoform binding antibodies and uses thereof
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
BRPI0606685A2 (pt) anticorpos gitr para o diagnóstico de nsclc
IL174195A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
DE602004022472D1 (de) Vorrichtung für Erkennung von Änderungsinformation
ATE533860T1 (de) Reagenzien und verfahren zur detektion von neisseria gonorrhoeae
DE60329861D1 (de) Neue, auf der antigen-antikörper-reaktion beruhende sondenplatte sowie reagenzienkit und verfahren mit verwendung der sondenplatte
GB0608377D0 (en) Reagents and methods